TCM Biotech International Corp. (TPEX:4169)

TCM Biotech International Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Apr 1, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	3,324	3,437	1,502	1,819	1,713	1,052
Market Cap Growth	-3.16%	128.87%	-17.43%	6.17%	62.78%	7.85%
Enterprise Value	2,872	3,518	1,592	1,930	1,741	1,150
Last Close Price	56.30	57.91	29.19	35.80	33.35	20.02
PE Ratio	163.31	185.02	82.21	970.95	67.06	161.56
PS Ratio	3.92	3.54	1.87	2.59	2.32	1.85
PB Ratio	3.17	3.26	2.80	3.51	3.31	2.06
P/TBV Ratio	3.19	3.28	2.85	3.60	3.41	2.09
P/FCF Ratio	70.04	-	30.98	162.55	23.80	-
P/OCF Ratio	65.98	-	28.74	118.66	22.87	-
EV/Sales Ratio	3.44	3.63	1.98	2.75	2.36	2.02
EV/EBITDA Ratio	60.51	89.02	38.95	117.57	34.58	40.89
EV/EBIT Ratio	108.80	157.56	62.91	905.86	46.99	83.93
EV/FCF Ratio	60.50	-	32.84	172.54	24.19	-
Debt / Equity Ratio	0.12	0.11	0.29	0.31	0.25	0.30
Debt / EBITDA Ratio	2.54	2.71	3.60	8.66	2.49	5.12
Debt / FCF Ratio	2.54	-	3.25	14.39	1.79	-
Asset Turnover	0.79	0.89	0.95	0.88	0.96	0.72
Inventory Turnover	2.18	2.44	1.79	1.67	1.82	1.66
Quick Ratio	4.68	3.87	1.42	1.42	1.74	1.65
Current Ratio	6.03	4.95	2.29	2.67	3.69	3.48
Return on Equity (ROE)	2.51%	2.33%	3.46%	0.36%	4.97%	1.24%
Return on Assets (ROA)	1.55%	1.28%	1.88%	0.17%	3.01%	1.09%
Return on Capital (ROIC)	1.77%	1.50%	2.30%	0.20%	3.54%	1.28%
Return on Capital Employed (ROCE)	2.40%	2.00%	4.00%	0.30%	5.60%	2.10%
Earnings Yield	0.60%	0.54%	1.22%	0.10%	1.49%	0.62%
FCF Yield	1.43%	-1.21%	3.23%	0.61%	4.20%	-2.20%
Dividend Yield	0.51%	0.49%	0.11%	-	1.05%	1.94%
Payout Ratio	8.09%	8.71%	-	903.20%	73.59%	274.18%
Buyback Yield / Dilution	-18.23%	-8.03%	-0.89%	-0.42%	0.03%	1.33%
Total Shareholder Return	-17.72%	-7.54%	-0.77%	-0.42%	1.08%	3.27%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.